Advertisement
Advertisement

Osteonecrosis in HIV-Positive Patients Is Associated With Increased Levels of CRP and D-dimer

May/June 2013

A retrospective case control study of 43 HIV positive patients with MRI-confirmed osteonecrosis of the femoral head (n=26 symptomatic, n=17 asymptomatic) found they had significantly elevated levels of the biomarkers C-reactive protein (CRP) and D-dimer compared to a control group of 50 HIV positive patients with negative MRI results.

This was a US study by Caryn Morse and colleagues from the National Institute of Health Clinical Centre and results were published as a concise communication in the 20 February 2013 edition of AIDS.1

All participants were already enrolled in other NIH studies, including a natural history study of osteonecrosis,

Advertisement
CRP (an inflammation marker commonly associated with cardiovascular disease) and D-dimer (a coagulation degradation product) have both been associated with increased risk of mortality and serious complications in HIV positive studies, independently of CD4 and viral load.

Samples were used from osteonecrosis diagnosis (+/- 2 months) and from at least 6 months prior to and post diagnosis for the active group, with the control using samples from the time of negative MRI and 6 months later. Values below the detection limit of the test were assigned a value of 0.21 mg/mL for D-dimer and of 0.16 mg/L for CRP.

Although baseline characteristics (at time of MRI) was similar for both groups, significant differences included longer duration of HIV infection (median 11.7 (range 1.6-19.5) vs 8.8 (0.4-16.4) years, p=0.003) and lower CD4 count (median 465 (range 12-1117) vs 686 (71-1705) cells/mm3, p=0.008) for the active vs control group respectively. Most participants were male (~90%) and on ART (~90%) with only 50% in each group having viral load <50 copies/mL. A high percentage of both groups had prior use of IL-2 (40% vs 60%, respectively).

Median levels of both D-dimer (0.32 vs 0.22 mg/mL; p=0.016) and CRP (2.52 vs 1.23 mg/L; p=0.003) were significantly higher in the active vs control group and remained significant after adjustment for viral load and anticardiolipin antibody status.

However, in linear regression analysis, the patterns of elevations were different for each biomarker after adjusting for viral load. D-dimer increased from the prediagnosis to diagnosis time point only in the osteonecrosis group (from 0.2 ug/L to 0.4 ug/L vs 0.2 ug/mL in controls). CRP levels remained stable (slope = zero) in each group over time. No difference was seen in D-dimer or CRP levels between the asymptomatic and symptomatic patients in the osteonecrosis group.

In the discussion section of the paper, the authors noted that elevations in D-dimer are associated with the development of osteonecrosis, but that CRP elevation predate the development of osteonecrosis, suggesting that at-risk patients have persistently higher levels of chronic inflammation; and that both markers could potentially help identify patients at higher risk of osteonecrosis.


Reference

Morse CG et al. Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults. AIDS 27(4):591-595. 20 February 2013. doi: 10.1097/QAD.0b013e32835c206a.

Links to other websites are current at date of posting but not maintained.




This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement